Mohammad Rezaul Quader, Mohammad Jahidur Rahman Khan, Arifa Akram, Md Shahidul Islam, Nusrat Mannan, Md Sabir Hossain, Nurul Karim, Farha Matin Juliana, Amirul Huda Bhuiyan, Paroma Deb, Farhana Khatoon, Farzana Mim, Md Selim Reza
{"title":"2019冠状病毒病与糖尿病:承认双向联系","authors":"Mohammad Rezaul Quader, Mohammad Jahidur Rahman Khan, Arifa Akram, Md Shahidul Islam, Nusrat Mannan, Md Sabir Hossain, Nurul Karim, Farha Matin Juliana, Amirul Huda Bhuiyan, Paroma Deb, Farhana Khatoon, Farzana Mim, Md Selim Reza","doi":"10.3329/bsmmcj.v1i2.69349","DOIUrl":null,"url":null,"abstract":"COVID-19 and diabetes mellitus have a dynamic and bidirectional relationship. Diabetes is a risk factor for COVID19. Diabetes mellitus is linked to hypercoagulability, inflammation, hyperglycemia, and other conditions (obesity, hypertension, cardiovascular disease, chronic kidney disease). Hyperglycemia may worsen SARS-CoV-2 infection. As a result of direct pancreatic damage caused by COVID-19, the stress response is triggered response to infection (including cytokine storm), including the use of hyperglycemic prescription medications such as corticosteroids for severe COVID-19, new-onset hyperglycemia and diabetes have been linked to the virus, as well as rapidly deteriorating blood glucose control in pre-existing diabetes. Insulin resistance and decreased b-cell secretion cause hyperglycemia. Challenges still remain in establishing the connection between COVID-19 and diabetes, whilst the pandemic progresses.
 Bangabandhu Sheikh Mujib Med. Coll. J. 2022;1(2):99-103","PeriodicalId":8681,"journal":{"name":"Bangabandhu Sheikh Mujib Medical University Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 and Diabetes: Acknowledging the Bidirectional Link\",\"authors\":\"Mohammad Rezaul Quader, Mohammad Jahidur Rahman Khan, Arifa Akram, Md Shahidul Islam, Nusrat Mannan, Md Sabir Hossain, Nurul Karim, Farha Matin Juliana, Amirul Huda Bhuiyan, Paroma Deb, Farhana Khatoon, Farzana Mim, Md Selim Reza\",\"doi\":\"10.3329/bsmmcj.v1i2.69349\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19 and diabetes mellitus have a dynamic and bidirectional relationship. Diabetes is a risk factor for COVID19. Diabetes mellitus is linked to hypercoagulability, inflammation, hyperglycemia, and other conditions (obesity, hypertension, cardiovascular disease, chronic kidney disease). Hyperglycemia may worsen SARS-CoV-2 infection. As a result of direct pancreatic damage caused by COVID-19, the stress response is triggered response to infection (including cytokine storm), including the use of hyperglycemic prescription medications such as corticosteroids for severe COVID-19, new-onset hyperglycemia and diabetes have been linked to the virus, as well as rapidly deteriorating blood glucose control in pre-existing diabetes. Insulin resistance and decreased b-cell secretion cause hyperglycemia. Challenges still remain in establishing the connection between COVID-19 and diabetes, whilst the pandemic progresses.
 Bangabandhu Sheikh Mujib Med. Coll. J. 2022;1(2):99-103\",\"PeriodicalId\":8681,\"journal\":{\"name\":\"Bangabandhu Sheikh Mujib Medical University Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bangabandhu Sheikh Mujib Medical University Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3329/bsmmcj.v1i2.69349\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangabandhu Sheikh Mujib Medical University Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/bsmmcj.v1i2.69349","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
COVID-19 and Diabetes: Acknowledging the Bidirectional Link
COVID-19 and diabetes mellitus have a dynamic and bidirectional relationship. Diabetes is a risk factor for COVID19. Diabetes mellitus is linked to hypercoagulability, inflammation, hyperglycemia, and other conditions (obesity, hypertension, cardiovascular disease, chronic kidney disease). Hyperglycemia may worsen SARS-CoV-2 infection. As a result of direct pancreatic damage caused by COVID-19, the stress response is triggered response to infection (including cytokine storm), including the use of hyperglycemic prescription medications such as corticosteroids for severe COVID-19, new-onset hyperglycemia and diabetes have been linked to the virus, as well as rapidly deteriorating blood glucose control in pre-existing diabetes. Insulin resistance and decreased b-cell secretion cause hyperglycemia. Challenges still remain in establishing the connection between COVID-19 and diabetes, whilst the pandemic progresses.
Bangabandhu Sheikh Mujib Med. Coll. J. 2022;1(2):99-103
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
